Fulton Bank’s Cardinal Health CAH Stock Holding History

Fulton Bank’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,537	Closed	-$256K	–	620
2023 Q4	$256K	Sell	2,537 -572	-18%	-$56.8K	0.01%	520
2023 Q3	$270K	Buy	+3,109	New	+$281K	0.01%	476

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fulton Bank's CAH Position: Q1 2024 in Review

Fulton Bank sold out of Cardinal Health (CAH) in Q1 2024, closing a stake of 2,537 shares — an estimated $256K sold.

Fulton Bank first reported a position in CAH in Q3 2023 and held it in 2 quarters. The position peaked at $270K in Q3 2023. 1,057 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

Fulton Bank reported no remaining Cardinal Health position as of Q1 2024 after selling out during the quarter.
Fulton Bank sold 2,537 Cardinal Health shares in Q1 2024, an estimated $256K.
Fulton Bank first reported a position in Cardinal Health in Q3 2023 and held it in 2 quarters.
Fulton Bank's Cardinal Health position peaked at $270K in Q3 2023.
1,057 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on Fulton Bank's 13F filing for Q1 2024, filed 10 Apr 2024.